• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟脱氧葡萄糖正电子发射断层扫描分期后结直肠癌肝转移切除的长期生存改善。

Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.

机构信息

Department of Surgery, Bristol Royal Infirmary, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

出版信息

J Surg Oncol. 2014 Sep;110(3):313-9. doi: 10.1002/jso.23623. Epub 2014 Apr 16.

DOI:10.1002/jso.23623
PMID:24737685
Abstract

BACKGROUND AND OBJECTIVES

Actual long-term survival of patients with colorectal liver metastases staged by PET CT has not been reported. Objectives were to investigate whether PET CT staging results in actual improved long-term survival, to examine outcome in patients with 'equivocal' PET CT scans, and those excluded from hepatectomy by PET CT.

METHODS

A retrospective analysis of patients undergoing hepatectomy for colorectal liver metastases between March 1998 and September 2008.

RESULTS

Overall 5- and 10-year survival was 44.8% and 23.9%. PET CT staging resulted in management changes in 23% of patients. PET CT staged patients showed significantly better survival than those staged by CT alone at 3 years (79.8% vs. 54.1%) and at 5 years (54.1% vs. 37.3%) with median survivals of 6.4 years versus 3.9 years (log rank P = 0.018). Patients with equivocal PET CT scans showed worse median survival than those with favourable PET CT (log rank P = 0.002), but may include a subpopulation whose prognosis trends towards a more favourable outcome than those excluded from liver resection by PET CT, whose median survival remains limited to 21 months.

CONCLUSIONS

Staging of patients with colorectal liver metastases by PET CT is associated with significantly improved actual long-term survival, and provides valuable prognostic information which guides surgical and oncological treatments.

摘要

背景与目的

PET CT 分期的结直肠癌肝转移患者的实际长期生存情况尚未见报道。本研究旨在探讨 PET CT 分期是否能真正改善长期生存,研究 PET CT 分期为“可疑”的患者和因 PET CT 而被排除肝切除术的患者的结局。

方法

回顾性分析 1998 年 3 月至 2008 年 9 月期间行肝切除术治疗结直肠癌肝转移的患者。

结果

总体 5 年和 10 年生存率分别为 44.8%和 23.9%。PET CT 分期使 23%的患者的治疗策略发生了改变。与 CT 单独分期的患者相比,PET CT 分期的患者在 3 年(79.8% vs. 54.1%)和 5 年(54.1% vs. 37.3%)时的生存率显著提高,中位生存时间分别为 6.4 年和 3.9 年(log rank P = 0.018)。PET CT 分期为“可疑”的患者的中位生存时间比 PET CT 分期为“有利”的患者差(log rank P = 0.002),但可能包括一部分预后趋势较好的患者,这些患者比因 PET CT 而被排除行肝切除术的患者的预后好,而后者的中位生存时间仍局限于 21 个月。

结论

结直肠癌肝转移患者的 PET CT 分期与显著改善的实际长期生存相关,并提供有价值的预后信息,指导手术和肿瘤治疗。

相似文献

1
Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.氟脱氧葡萄糖正电子发射断层扫描分期后结直肠癌肝转移切除的长期生存改善。
J Surg Oncol. 2014 Sep;110(3):313-9. doi: 10.1002/jso.23623. Epub 2014 Apr 16.
2
Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.对术前化疗的代谢反应可预测接受手术切除肝转移结直肠癌患者的预后。
Ann Surg Oncol. 2014 Jul;21(7):2420-8. doi: 10.1245/s10434-014-3590-0. Epub 2014 Mar 5.
3
FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases.氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(FDG-PET-CT)在筛选结直肠癌肝转移长期生存率低的患者方面很有效。
Eur J Surg Oncol. 2014 Aug;40(8):995-9. doi: 10.1016/j.ejso.2013.10.026. Epub 2013 Nov 15.
4
F18-FDG-PET evaluation of patients for resection of colorectal liver metastases.对结直肠癌肝转移患者进行F18氟代脱氧葡萄糖正电子发射断层显像(F18-FDG-PET)评估以确定是否适合手术切除。
Hepatogastroenterology. 2007 Sep;54(78):1667-71.
5
Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery.多期CT、FDG-PET与术中超声在择期手术的结直肠癌肝转移患者中的比较。
Ann Surg Oncol. 2007 Feb;14(2):818-26. doi: 10.1245/s10434-006-9259-6. Epub 2006 Nov 29.
6
Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.(18)F-氟代脱氧葡萄糖(FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)对侵犯膀胱肌肉的癌患者管理的影响。
BJU Int. 2013 Oct;112(6):729-34. doi: 10.1111/bju.12109. Epub 2013 Jun 24.
7
Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.术前FDG-PET-CT检查显示患有结直肠癌且伴有可切除肝转移的患者的术中超声检查
J Clin Ultrasound. 2008 Jan;36(1):20-6. doi: 10.1002/jcu.20408.
8
Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.利用(18)F-FDG PET改善结直肠癌肝转移肝手术患者的选择:一项随机研究。
J Nucl Med. 2009 Jul;50(7):1036-41. doi: 10.2967/jnumed.109.063040. Epub 2009 Jun 12.
9
Prognostic significance of F-FDG PET/CT in patients with colorectal cancer liver metastases after hepatectomy.结直肠癌肝转移患者肝切除术后 F-FDG PET/CT 的预后意义。
Eur J Surg Oncol. 2018 May;44(5):670-676. doi: 10.1016/j.ejso.2018.01.243. Epub 2018 Feb 6.
10
Controversies in the management of colorectal liver metastases: role of PET and PET/CT.结直肠癌肝转移管理中的争议:PET及PET/CT的作用
Dig Surg. 2008;25(6):413-20. doi: 10.1159/000184732. Epub 2009 Feb 12.

引用本文的文献

1
Colorectal liver metastases: Current management and future perspectives.结直肠癌肝转移:当前治疗与未来展望
World J Clin Oncol. 2020 Oct 24;11(10):761-808. doi: 10.5306/wjco.v11.i10.761.
2
Current status of surgical treatment of colorectal liver metastases.结直肠癌肝转移的外科治疗现状
World J Clin Cases. 2018 Nov 26;6(14):716-734. doi: 10.12998/wjcc.v6.i14.716.
3
Mortality-related risk factors and long-term survival after 4460 liver resections in Sweden-a population-based study.瑞典4460例肝切除术后的死亡相关危险因素及长期生存——一项基于人群的研究
Langenbecks Arch Surg. 2017 Feb;402(1):105-113. doi: 10.1007/s00423-016-1512-2. Epub 2016 Oct 1.